Minimal Invasive Surgery in Total Hip Arthroplasty Patients; Strength, Functionality and Post Operative Complications

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Completed
CT.gov ID
NCT01959360
Collaborator
St. Olavs Hospital (Other)
59
1
3
88
0.7

Study Details

Study Description

Brief Summary

The aim of the present study is to explore the most efficient surgical approach in total hip replacement in short and long term when concerning strength, functionality and postoperative complications.

The objective is to register muscular strength, hip joint functionality/mobilisation and complications after total hip arthroplasty (THA) performed by two minimal invasive/incision surgeries (MIS) versus the traditionally lateral approach.

The primary working hypothesis is that due to a minimal dissection and reduced trauma in the muscles, patients will tolerate early hospital discharge better after MIS than after traditional lateral surgery. Patients in the MIS group will also be more active and maintain muscular strength and hip joint functionality/mobilisation better than patients in the lateral group.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Direct lateral
  • Procedure: minimal invasive
  • Procedure: modified minimal invasive
N/A

Detailed Description

With total hip replacement surgery, the orthopaedic surgeon's aim is not only pain relief for the patient, but also restoration of hip joint biomechanics resulting in a minimal functional deficit and maximal longevity of the implant. It is not exceptional that these patients still experience mild to moderate long-term impairments postoperatively. These impairments include pain, muscle weakness of the hip abductors, contracture of the hip, gait disorders, as well as weakness of hip extensors and flexors. These problems may in turn lead to complications such as joint instability and loosening of the implant. When the lateral surgical approach is used, major concerns after total hip replacement surgery are muscle abductor weakness/atrophy, tendon defects of the gluteus minimus muscle, and unsuccessful reattachment or denervation of the anterior gluteal flap.

Minimal incision/invasive surgery (MIS) is defined as a surgical approach performed through a short skin and muscle incision to avoid injury to muscles and tendons. Following minimally invasive approach reduced muscle trauma has been found. Moreover clinical outcome improved, as the gluteus medius muscle can be spared more successfully. However, it is debated whether or not the overall results of MIS are superior, or even as good as the traditional hip replacement surgery in terms of component placing and time to revision of the prosthesis.

Study Design

Study Type:
Interventional
Actual Enrollment :
59 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Minimal Invasive Surgery in Total Hip Arthroplasty Patients; Strength, Functionality and Post Operative Complications
Actual Study Start Date :
Aug 1, 2011
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: direct lateral

Procedure: Direct lateral
Total hip replacement; direct lateral approach

Experimental: minimal invasive

Procedure: minimal invasive
Total hip replacement; minimal invasive approach

Experimental: modified minimal invasive

Procedure: modified minimal invasive
Total hip replacement; modified minimal invasive approach

Outcome Measures

Primary Outcome Measures

  1. Implant stability [2 years]

Secondary Outcome Measures

  1. Implant stability [5 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients scheduled for THA

  • Diagnosis of primary osteoarthritis as the main cause for elective THA

  • American Society of Anesthesiologists (ASA) score I, II, and stable III

Exclusion Criteria:
  • Musculoskeletal diseases

  • Current heart/pulmonary- or malignant diseases likely to influence the physical testing performance.

Contacts and Locations

Locations

Site City State Country Postal Code
1 St Olavs Hospital Trondheim Norway

Sponsors and Collaborators

  • Norwegian University of Science and Technology
  • St. Olavs Hospital

Investigators

  • Study Director: Lars Jacob Stovner, prof, Norwegian University of Science and Technology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01959360
Other Study ID Numbers:
  • 100889
First Posted:
Oct 10, 2013
Last Update Posted:
May 15, 2019
Last Verified:
May 1, 2019
Keywords provided by Norwegian University of Science and Technology
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 15, 2019